FDA
- Status: approved
pegylated interferon alpha 2a and ribavirin (pegylated interferon alpha 2a and ribavirin) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Kaohsiung Medical University Chung-Ho Memorial Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.